Skip to main content

Type 1 Discovery magazine

Type 1 Discovery magazine brings you real-life stories of people living with type 1, in-depth interviews with researchers who are changing lives with their work, and the latest type 1 tech innovations that are helping to improve treatment for many.
Content last reviewed and updated: 15.08.2023

Front cover of Issue 94 Type 1 Discovery magazine

Published three times a year, Type 1 Discovery is packed with features, news, updates and ways to get involved with JDRF. In the current issue you’ll find:

  • Our cover star Tom Ball talks about Britain’s Got Talent and finding community.
  • Professor Partha Kar speaks about his work and the future of type 1 diabetes in the UK.
  • Berni Warren shares her experience of living with type 1 and eye complications.
  • Dr Fiona Docherty talks about her love of research.
  • Many other people who are living with type 1 who talk about their experiences
  • Ways to get involved in supporting JDRF’s research to treat, prevent and cure type 1

Get a FREE copy

Sign up using the form below and receive your first free copy of Type 1 Discovery soon!

Type 1 diabetes news

Read more
Nina Willer, who used hybrid closed loop technology through pregnancy, and her child.
Treatment research
7 November 2023

Hybrid closed loop technology set to be made available in England and Wales

The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.

Read more
T cell immune system
6 November 2023

New research highlights the effectiveness of immune therapies for type 1 diabetes

The research, which was co-funded by JDRF, reveals that drugs that target the immune system offer very effective and rapid improvements in stabilising blood sugar levels, often within just three months.

Read more
Dr Ify Mordi, lead type 1 diabetes researcher
Clinical trials
25 October 2023

JDRF award £1.5 million grant to University of Dundee for type 1 diabetes clinical trial

The new JDRF-funded clinical trial called SOPHIST will test a drug to help people with type 1 diabetes and heart failure.

Read more
Young person receiving an injection of the immunotherapy drug teplizumab.jpg
18 October 2023

Clinical trial finds teplizumab slows type 1 diabetes in people newly diagnosed 

Results from a clinical trial called the PROTECT study show that teplizumab can preserve beta cell function in children and adolescents newly diagnosed with type 1 diabetes.